1.  The AAP, together with the CDC, ACIP, and AAFP, is recommending that, effective immediately, providers administer 3 doses of conjugated pneumococcal vaccine (PCV7 or Prevnar).  Children for whom the third dose was deferred may be called back for its administration at this time.  The fourth dose should still be deferred for healthy children until further notice.  Problems with production of this vaccine appear to have been resolved and supply across the country is stabilizing. 

2.  The full 4-dose series should continue to be given to children at increased risk for pneumococcal disease.  Alaska Native children and American Indian children living in Alaska, Arizona, or New Mexico, and Navajo children in Utah and Colorado should receive 4 doses because their risk of invasive disease is currently more than twice the national average.

Providers having questions about their allocation or about obtaining PCV7 should contact Wyeth's customer service department at 1-800-666-7428.  For issues not resolved by customer service, call Rosemary Talley at Wyeth at 1-800-666-7248.

Details regarding these recommendations including a catch-up table can be found at:  http://www.cdc.gov/mmwr/